PIK3CA and ovarian carcinoma: PIK3CA (3/10, 30%), TP53 (2/10, 20%), MCL1 (2/10, 20%), and JUN (2/10, 20%) also showed noted copy number variations in drug‐resistant recurrent ovarian cancer and were specific for drug‐resistant recurrent ovarian cancer.